• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[牛纤维蛋白原接受并保留人血特异性纤溶酶原激活剂的能力]

[Ability of bovine fibrinogen to accept and retain plasminogen proactivator specific for human blood].

作者信息

Belitser V A, Varetskaia T V, Tsariuk L A

出版信息

Ukr Biokhim Zh. 1976;48(6):721-6.

PMID:1034991
Abstract

The plasminogen proactivator present in human plasma and retained by purified human fibrinogen preparations is readily accepted and retained by bovine fibrinogen. This "transplantation" makes isolated bovine fibrinogen susceptible to streptokinase. The latter induces degradation of isolated bovine fibrinogen resulting in characteristic fragment formation. Our experimental results, particularly those showing the inability of bovine plasminogen (applied in a great excess) to remove the acquired proactivator from bovine fibrinogen, give indirect evidence that the proactivator function is not a specific property of the human plasminogen but that of some other substance.

摘要

人血浆中存在的纤溶酶原激活剂以及纯化的人纤维蛋白原制剂所保留的该激活剂,很容易被牛纤维蛋白原接受并保留。这种“移植”使分离出的牛纤维蛋白原对链激酶敏感。后者会诱导分离出的牛纤维蛋白原发生降解,导致特征性片段形成。我们的实验结果,尤其是那些表明大量应用的牛纤溶酶原无法从牛纤维蛋白原中去除获得性激活剂的结果,间接证明了激活剂功能并非人纤溶酶原的特异性属性,而是其他某种物质的属性。

相似文献

1
[Ability of bovine fibrinogen to accept and retain plasminogen proactivator specific for human blood].[牛纤维蛋白原接受并保留人血特异性纤溶酶原激活剂的能力]
Ukr Biokhim Zh. 1976;48(6):721-6.
2
A method for the measurement of fibrinolytic activity based on one dimensional diffusion using small glass tubes. II. With special reference to the differences between the use of plasminogen-rich fibrinogen and that of plasminogen-free fibrinogen as the substrates.一种基于使用小玻璃管进行一维扩散来测量纤溶活性的方法。II. 特别提及以富含纤溶酶原的纤维蛋白原和不含纤溶酶原的纤维蛋白原作为底物时的差异。
Thromb Haemost. 1977 Jun 30;37(3):456-63.
3
The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator--role of fibrin degradation products.在血管纤溶酶原激活物存在的情况下产生的一种增强剂可增强SK-纤溶酶原复合物的酰胺分解活性——纤维蛋白降解产物的作用。
Thromb Haemost. 1982 Jun 28;47(3):193-6.
4
Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.吸血蝙蝠唾液纤溶酶原激活剂可在血浆环境中促进血浆凝块的强力溶解,而不会引起液相纤溶酶原激活。
Thromb Haemost. 1992 Aug 3;68(2):165-9.
5
The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.易发生血栓形成的患者群体中的止血平衡。特别提及心肌梗死患者的纤维蛋白溶解。
Dan Med Bull. 1990 Jun;37(3):210-34.
6
[Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].[人血浆纤维蛋白溶解中的前激活剂-激活剂系统:关于从人血浆中分离出的由功能纯的纤维蛋白原、纤溶酶原和前激活剂组成的合成纤维蛋白溶解系统的研究]
Nihon Seirigaku Zasshi. 1972 Mar;34(3):147-55.
7
Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product.人血浆中纤溶酶原激活的链激酶依赖性增强因子(SK增强因子):鉴定为纤维蛋白原降解产物。
J Biochem. 1982 Oct;92(4):1129-40. doi: 10.1093/oxfordjournals.jbchem.a134029.
8
[Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].[单次给予组织型纤溶酶原激活剂对大鼠血液纤溶系统状态的影响]
Vopr Med Khim. 1981 Jan-Feb;27(1):77-80.
9
[Method of determination of total content of plasminogen, plasminogen proactivator, inhibitors of plasminogen activation and antiplasmins in the blood plasma].[血浆中纤溶酶原、纤溶酶原激活物、纤溶酶原激活抑制剂及抗纤溶酶总含量的测定方法]
Lab Delo. 1977(9):530-2.
10
A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples.
Thromb Haemost. 1985 Apr 22;53(2):255-9.